NOV 01, 2017 09:00 AM PDT

WEBINAR: Clinical Applications and Strategies Using Procalcitonin (PCT) to Improve Patient Outcomes

SPONSORED BY: Abbott Molecular
C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Director of Critical Services Swedish Covenant Hospital
      Eric Howard Gluck, M.D. received his medical degree in medicine from New York Medical College in Valhalla, New York. He completed his residency at Beth Israel Medical Center in New York City and a pulmonary fellowship at the University of Utah School of Medicine in Salt Lake City, Utah. He currently serves as the director of Critical Care Services and Chief Academic Officer at Swedish Covenant Hospital in Chicago, Illinois. In addition, Dr. Gluck is a Professor of Medicine at the Finch University of Health Sciences/The Chicago Medical School. Dr. Gluck is part of many professional societies. Most notably, he is a fellow of the Society of Critical Care Medicine, the American College of Chest Physicians, and the Chicago Institute of Medicine. He is a member of the American Thoracic Society, the Society of Sigma Xi, Alpha Omega Alpha, and the American Society of Law, Medicine, and Ethics. He has presented lectures and authored many peer reviewed articles and chapters in the field of pulmonary critical care and has been in practice for more than 20 years. More recently, Dr. Gluck has been leader at developing and implementation strategies at his institution to reduce the risk of sepsis in critically ill patients.


    DATE:  November 1, 2017

    TIME:  9:00am PT, 12:00pm ET

    Over 1.6 million people are diagnosed with sepsis in the U.S. each year1 and sepsis is the #1 cost of hospitalization (over $24 billion each year)1. Having a biomarker that can quickly identify sepsis is critical because mortality increases 8% every hour that treatment is delayed1.

    Procalcitonin (PCT) helps determine if the patient has a bacterial infection (sepsis), the severity of the infection and is the patient responding to therapy2. PCT is a more accurate diagnostic parameter for sepsis and a better predictor of mortality and a more reliable marker than other biomarkers3. PCT also provides clinicians a mechanism for antibiotic stewardship2.

    1. Sepsis Alliance Website:
    2. Thermo Scientific B-R-A-H-M-S PCT Improving infection management.
    3. Shiferaw, et al. The Role of Procalcitonin as a Biomarker in Sepsis. J Infect Dis Epidemiology. 2016;2:006 Vol 2.

    Expected Outcomes:

    • Understand the clinical utility of PCT.
    • Incorporate  PCT protocols as part of sepsis management.
    • Demonstrate the impact PCT can have on clinical and financial outcomes


    Show Resources
    Loading Comments...